EDXC Could Explode - Big News Just Out
Published: Wed, 11/01/23
 Subscribers, We've got a brand new, hot low priced, low float ticker to sink your teeth into today. Endexx, Corp (EDXC) is priced at just $0.028 and has a chart worth salivating over. Tightly wound and coiled, ready to pop with the right catalyst. And today's news is exactly what the trading doctor ordered. Endexx Featured on Small Cap VoiceHYLA Targets 300% Growth Rate Per Year CAVE CREEK, AZ, Nov. 01, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, today announced a shareholder update for progress in 2023 and that Endexx is being featured on SMALL CAP VOICE with Stuart Smith. See Video at: https://youtu.be/6D2vlhy-jWU Since acquiring HYLA, Endexx has accelerated its revenue and international distribution quicker than anticipated, exceeding first year expectations. Highlights include:
“Endexx has dramatically expanded its revenues on plant-based consumer products and its international footprint over the past year. Pivoting in 2022 to acquire HYLA was a key factor in our success in 2023,” stated Todd Davis, CEO of Endexx. Mr. Davis added, “Going forward, momentum is building for HYLA’s products, with anticipated annual growth for the next 3-5 years of 250-500 percent annually.” “While the past year has been challenging, we really are seeing incredible traction for Hyla products both domestically and abroad,” says Hyla CEO Nick Mehdi. “We are looking forward to an incredibly strong next year driven by both growing reorders from existing customers and expansion into some very exciting new markets over the coming quarters.” https://www.globenewswire.com/news-release/2023/11/01/2771186/0/en/Endexx-Featured-on-Small-Cap-Voice.htmlAbout EDXC... EDXC develops and distributes all natural, plant-derived wellness products and topical skincare products. Its products vary from balms, creams, lotions, butters, masks, scrubs, and oils, all with the shared purpose of healthy skin and grooming wellness. The science behind these products involves a decade of clinical research in the field and lab work to provide functional formulation with ingredients for optimal absorption
and support of skin health. www.endexx.com Hyla currently markets its proprietary non-nicotine, guarana and L-Dopa-based vape products in a wide variety of flavors. The Hyla device is the first non-nicotine vape product to be produced in this manner in the United States and provides an unprecedented 4,500 puffs per device. Hyla is currently being distributed in 10 countries and has signed distribution agreements with an additional nine countries. www.tryhyla.com EDXC is a diverse company with global and domestic operations. EDXC is also involved in joint ventures with strategic partners in the entertainment, marketing, and distribution arenas. The company has made strategic acquisitions over the last several years that are now cohesively accelerating the company into its revenue growth stage. The EDXC Management Team and its advisory group each have a minimum 10-50 years of experience in their respective fields. The professionals all have experience in growing businesses, developing, and implementing new consumer products and technologies with an emphasis in the medical, biotech and life science industries.
EDXC Drivers EDXC incorporates science and compliance as the foundation for the development of all its products. Utilizing high quality functional ingredients to formulate our products, most customers have positive experiences which outperform their expectations. This is what differentiates the Endexx line of products in the market. CBD Unlimited, a subsidiary of EDXC and founded in 2014, is based upon the belief that cannabidiol (CBD), combined with plant-based nutrients will unlock a new frontier in natural healing. With a biotech background stretching back to the early 90’s, founder, Todd Davis quickly identified that the young industry faced a major challenge, nobody knew how to measure and control dosage with a predictable outcome when utilizing hemp derived molecules. EDXC capitalized on this by immersing itself into the “2014 Hemp Pilot Program”. The company was determined to find the answers. EDXC recruited multiple doctors and their volunteer patients who were excited about the new potential applications derived from hemp. The doctors lead adaptive clinical studies in four separate locations throughout the country. There were 180 volunteer patients that helped define effective dosing ranges for each delivery system tested. All products are built on this scientific foundation. Research continues as we build statistical models that will lead to peer reviewed scientific analysis, helping to advance the science of CBD. Today, CBD is everywhere, but few companies have invested the time, resources, and care in formulating properly dosed, high-value products for the consumer. Endexx is a USA company advancing the “science and compliance” in the Hemp Industry. Endexx launched a motto initiative in 2016 that it still abides by: “Better Products Better You” and “Live Life Unlimited”. In 2021, Endexx and its celebrity partner DJ Khaled launched a Men’s Grooming Line named Blesswell™ Khaled’s new slogan is “Live Well, Love Well, Blesswell.” www.BLESSWELL.co Blesswell will be available in many big box chains in the very near future and is forecasted to be a household name over the next 1-3 years. You can learn more about EDXC at their website https://endexx.com/Recent News... Endexx Announces Amended Consolidated 10-Q/A: Quarterly Report for The Quarter Ending March 31, 2023, Increasing Year-Over-Year 1013%Endexx Year Over Year Six Month Revenues Grew 528% CAVE CREEK, AZ, Sept. 19, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, announced today the filing of its amended, consolidated, audited 10-Q/A Quarterly report for the quarter ending March 31, 2023. Endexx Milestones and Highlights for the quarter ending March 31, 2023 ● Year-over-year quarterly revenues increased 1013% from $254,686 to $2,833,378. ● For the six months ended March 31, 2023, Endexx recorded a 528% increase in revenue, from $529,277 to $3,326,087 Year-Over-Year for the same period. ● Six-month losses year-over-year improved, March 31, 2023 were $2,584,678 compared to $4,426,299 in the same period of fiscal 2022. “Consolidating the audited financials and integrating Hyla's operations into Endexx, we've catapulted into an era marked by unprecedented growth, painting Fiscal 2023 as a canvas of resurgence and robust expansion amidst a two-year stagnation in the cannabis and hemp industry," said Todd Davis. "This synergy has not just revitalized our foothold in the domestic market but has also catapulted us onto the global stage, significantly multiplying our retail presence into 11 countries, particularly during the initial half of Fiscal 2023." https://finance.yahoo.com/news/endexx-announces-amended-consolidated-10-123000324.htmlEndexx Secures $2.0M Purchase Order for Non-Nicotine Vape Product HYLA From Sahara Trading UAEEndexx’s HYLA Division Continues to Penetrate New Global Markets CAVE CREEK, AZ, Aug. 09, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire – Endexx® Corporation (OTCQB: EDXC), a provider of innovative plant-based wellness and nutritional products, today announced it has secured a $2.0 million USD order for its non-nicotine vape product, HYLA, from Sahara Trading UAE. The purchase order marked the first of the previously announced eight country territory deal with Sahara Trading UAE in the greater “Middle East Territories” in June 2023. Unit production for the first order is expected to start by the end of the week with the first shipments to be sent out in September 2023. “HYLA is excited for Sahara Trading UAE to execute the previously announced distribution agreement as we continue to grow our global distribution network,” said Nick Mehdi, CEO of HYLA. “We anticipate multiple orders in the coming quarters from additional purchase agreements with Sahara Trading.” “Our international distribution partners are continuing to show strong demand for Endexx’s non-nicotine, plant-based HYLA vape products,” said Davis, CEO of Endexx Corporation. “Since the acquisition of HYLA in August 2022, HYLA sales have steadily increased, and we are now starting to see the product rapidly expand into new global markets.” https://finance.yahoo.com/news/endexx-secures-2-0m-purchase-123000175.htmlGet EDXC on your screen immediately. This could move big and fast and we don't want you to miss out. All the best. SmallCapMomo.com picks@smallcapmomo.com --------------------------------------------------------------------------------------------------------
Remember our key trading rules when trading. Capital preservation is key. Keep your stops tight, and if things don't go your way, cut your losses and look for another opportunity. Disclaimer Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment. For full disclaimer click here. SmallCapMomo.com is the property of Alpha Stock Media. SmallCapMomo.com employees are not registered as an Investment Adviser in any jurisdiction whatsoever. The disclaimer is to be read and fully understood before using our site, or joining our email list. None of the materials or advertisements herein constitute offers or solicitations to purchase or sell securities of the companies profiled herein and any decision to invest in any such company or other financial decisions should not be made based upon the information provide herein. Instead SmallCapMomo.com strongly urges you conduct a complete and independent investigation of the respective companies and consideration of all pertinent risks. SmallCapMomo.com does not offer such advice or analysis, and SmallCapMomo.com further urges you to consult your own independent tax, business, financial and investment advisors. Investing in micro-cap and growth securities is highly speculative and carries and extremely high degree of risk. It is possible that an investor's investment may be lost or impaired due to the speculative nature of the companies profiled. Any statements that express or involve discussions with respect to predictions, expectations, beliefs, plans, projections, objectives, goals, assumptions or future events or performance are not statements of historical fact may be "forward looking statements". Forward looking statements are based on expectations, estimates, and projections at the time the statements are made that involve a number of risks and uncertainties which could cause actual results or events to differ materially from those presently anticipated. Forward looking statements in this action may be identified through use of words such as "projects", "foresee", "expects", "will", "anticipates", "estimates", "believes", "understands", or that by statements indicating certain actions "may", "could", or "might" occur. Understand there is no guarantee past performance will be indicative of future results. In preparing this publication, SmallCapMomo.com has relied upon information supplied by its customers, and press releases which it believes to be reliable; however, such reliability cannot be guaranteed. Investors should not rely on the information contained in this website. Rather, investors should use the information contained in this website as a starting point for doing additional independent research on the featured companies. The advertisements in this website are believed to be reliable, however, SmallCapMomo.com and its owners, affiliates, subsidiaries, officers, directors, representatives and agents have not completed any due diligence or research on the companies advertised herein and disclaim any liability as to the completeness or accuracy of the information contained in any advertisement and for any omissions of materials facts from such advertisement. SmallCapMomo.com is not responsible for any claims made by the companies advertised herein. SmallCapMomo.com may receive compensation and they, its employees and/or affiliates may own stock that they have purchased in the open market either prior, during, or after the release of the companies profile which is an inherent conflict of interest in SmallCapMomo.com statements and opinions and such statements and opinions cannot be considered independent. SmallCapMomo.com reserves the right to buy and sell shares of the profiled company on the open market before, during or after the release of the company profile. In such an event, SmallCapMomo.com will not update its disclaimer to reflect any shares bought or sold on the open market during the profile coverage. SmallCapMomo.com and its management may benefit from any increase in the share price of the profiled companies and hold the right to close positions they have entered into at any given time including before or after the release of the companies profile. Alpha Stock Media has been compensated one thousand dollars via electronic transfer from a non-affiliated third party for the profile of EDXC. SmallCapMomo.com does not accept compensation in restricted or free-trading shares for its marketing services of the company being profiled. However the third party that has compensated SmallCapMomo.com may hold free-trading shares of the company being profiled and could very well be selling shares of the company’s stock at the same time the profile is being disseminated to potential investors; this should be viewed as a definite conflict of interest and as such, the reader should take this into consideration. If SmallCapMomo.com ever does accept compensation in the form of restricted or free trading shares of the company being profiled and decides to sell these shares into the public market at any time before, during, or after the release of the companies profile our disclaimer will be updated accordingly reflecting the position of those free trading shares received as compensation for our services at the time our promotional material is released to the public, as well as information on our intention to sell these shares during the promotional period or thereafter. |